John R. Borzilleri, MD is the portfolio manager for the GRT Health Care strategy. Dr. Borzilleri has been involved with health care investment management and research since 1991.
Dr. Borzilleri was the portfolio manager of the State Street Research Health Sciences Fund from its inception in December 1999 until June 2003. For the three years ending June 2003, the Health Sciences Fund achieved annualized returns that earned it the #1 ranking by Lipper of more than 70 health care mutual funds.
From 1997 through 2003, Dr. Borzilleri was also a senior health care analyst at State Street Research, providing broad coverage of the pharmaceutical, biotechnology and medical service sectors. During his last two years at State Street Research, Dr. Borzilleri served as health care sector head, with responsibility for supervising a team of three analysts.
From October 1995 to June 1997, Dr. Borzilleri was the senior pharmaceutical analyst at San Francisco-based Montgomery Securities, with analytic responsibility for large, mid and small capitalization drug companies. From October 1993 to October 1995, Dr. Borzilleri was the senior pharmaceutical and biotechnology analyst at Dean Witter in New York. From August 1991 to October 1993, Dr. Borzilleri was a junior pharmaceutical and biotechnology analyst at Sanford Bernstein.
Dr. Borzilleri holds a BS degree in Biology from Brown University ('81), an MD from New York University ('85) and an MBA from Columbia University ('91). Between medical and business school, Dr. Borzilleri trained as a resident and practiced medicine.